Cytokine inflammatory modulators

Cytokine inflammatory modulators represent a broad functional class of proteins and signaling pathways rather than a single molecular target [NIH]. This category includes pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), which are pivotal in orchestrating the body's immune response to pathogens and injury [PubMed]. While essential for host defense, the dysregulated or chronic expression of these modulators is a primary driver of tissue damage in autoimmune and autoinflammatory diseases [StatPearls]. Therapeutic strategies targeting these modulators involve the use of monoclonal antibodies to neutralize circulating cytokines, decoy receptors to sequester ligands, or small molecule inhibitors (such as JAK inhibitors) to block downstream intracellular signaling [Nature Reviews Drug Discovery]. These interventions are widely used to treat conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease, though they require careful monitoring due to their impact on systemic immune surveillance [Frontiers in Immunology].

Other names

Cytokine modulatorsBiological response modifiersInflammatory cytokine inhibitorsAnti-inflammatory cytokine agentsCytokine signaling modulators

Inhibition of pro-inflammatory signaling through ligand neutralization, competitive receptor antagonism, or inhibition of intracellular signal transducers such as Janus kinases (JAKs).